Hyperthyroidism and lupus-like syndrome in an adolescent treated with minocycline for acne vulgaris

Pediatric Dermatology

Volumn 24, Issue 3, 2007, Pages 246-249

  Benjamin, Robert W ^a,b   Calikoglu, Ali S ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b 3341 MBRB ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; LEVOTHYROXINE; MINOCYCLINE; THIAMAZOLE;

ACNE VULGARIS; ADOLESCENCE; ADOLESCENT; ARTICLE; CASE REPORT; CLINICAL FEATURE; DRUG DOSE REDUCTION; DRUG SAFETY; DRUG WITHDRAWAL; FOLLOW UP; HUMAN; HYPERTHYROIDISM; LABORATORY TEST; LUPUS LIKE SYNDROME; MALE; PHYSICAL EXAMINATION; PRIORITY JOURNAL; TACHYCARDIA; THYROID FUNCTION TEST; TREATMENT INDICATION; TREATMENT OUTCOME; TREMOR;

ACNE VULGARIS; ADOLESCENT; ANTI-BACTERIAL AGENTS; HUMANS; HYPERTHYROIDISM; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MINOCYCLINE; TACHYCARDIA;

EID: 34249787362     PISSN: 07368046     EISSN: 15251470     Source Type: Journal    
DOI: 10.1111/j.1525-1470.2007.00395.x     Document Type: Article

References (21)

1. Klein NC, Cunha BA. Tetracyclines. Med Clin North Am 1995 79 : 789 801.
2. Allen JC. Minocycline. Ann Intern Med 1976 85 : 482 487.
3. Tilley BC, Alarcon GS, Heyse SP et al. Minocycline in rheumatoid arthritis. A 48-week, double-blind, placebo-controlled trial. MIRA Trial Group. Ann Intern Med 1995 122 : 81 89.
4. Zemke D, Majid A. The potential of minocycline for neuroprotection in human neurologic disease. Clin Neuropharmacol 2004 27 : 293 298.
5. Freeman K. Therapeutic focus. Minocycline in the treatment of acne. Br J Clin Pract 1989 43 : 112 115.
6. Eichenfield AH. Minocycline and autoimmunity. Curr Opin Pediatr 1999 11 : 447 456.
7. Schlienger RG, Bircher AJ, Meier CR, Minocycline-induced lupus. A systematic review. Dermatology 2000 200 : 223 231.
8. Hakim ED. Minocycline-induced pigmentation. Incidence, prevention and management. Drug Safety 1998 18 : 431 440.
9. LaFranchi SH, Hanna CE. The thyroid gland and its disorders. In : Kappy MS, Allen DB, Geffner ME, eds. Principles and practices of pediatric endocrinology. Springfield : Charles C Thomas, 2005.
10. Fisher DA. Hashimoto (autoimmune) thyroiditis. In : Sperling MA, ed. Pediatric endocrinology, 2nd ed. Philadelphia : Elsevier Science, 2002.
11. Taurog A, Dorris ML, Doerge DR. Minocycline and the thyroid: antithyroid effects of the drug, and the role of thyroid peroxidase in minocycline-induced black pigmentation of the gland. Thyroid 1996 6 : 211 219.
12. Nollevaux MC, Burlet M, Squifflet JP et al. Is the black thyroid really an innocuous pathological finding? Acta Clin Belg 2002 57 : 158 161.
13. Birkedal C, Tapscott WJ, Giadrosich K et al. Minocycline-induced black thyroid gland: medical curiosity or a marker for papillary cancer? Curr Surg 2001 58 : 470 471.
14. Alexander CB, Herrera GA, Jaffe K et al. Black thyroid: clinical manifestations, ultrastructural findings, and possible mechanisms. Human Pathol 1985 16 : 72 78.
15. Saito K, Jujio T, Hashizumi I et al. Studies on the goitrogenic action of minocycline and related compounds. Endocrinology 1972 90 : 1192 1201.
16. Griffen JE. The thyroid. In : Griffen JE, Ojeda SR, eds. Textbook of endocrine physiology, 5th ed. New York : Oxford University Press, Inc., 2004 : 294 298.
17. Teicher BA, Sotomayor EA, Huang ZD. Antiangiogenic agents potentiate cytotoxic cancer therapies against primary and metastatic disease. Cancer Res 1992 52 : 6702 6704.
18. Baker JR Jr., Saunders NB, Wartofsky L et al. Seronegative Hashimoto thyroiditis with thyroid autoantibody production localized to the thyroid. Ann Intern Med 1988 108 : 26 30.
19. Matsuura T, Shimizu Y, Fujimoto H et al. Minocycline-related lupus. Lancet 1992 340 : 1553.
20. Shepherd J. Severe complication of a commonly prescribed drug: minocycline-induced lupus. J Am Board Fam Pract 2002 15 : 239 241.
21. Dunphy J, Oliver M, Rands AL et al. Antineutrophil cytoplasmic antibodies and HLA class II alleles in minocycline-induced lupus-like syndrome. Br J Dermatol 2000 142 : 461 467.